Basic Information
Dynakin is a contract research organization specializing in GLP bio-laboratories and model-based drug development services, with a focus on Model-Informed Drug Development (MIDD). Dynakin employs state-of-the-art industry and regulatory standard pharmacometric methodologies to maximize efficiency, minimize risks and costs during development, and provide the shortest path to success for your drug development. The company has extensive expertise in implementing and supporting partners and clients in applying PK/PD modeling and simulation tools throughout the R&D process of drug development, from preclinical, FTIM, Phase I to Phase III and Phase IV clinical trials. Dynakin's DMC team has strong application capabilities in modeling and simulation for drug development and bioequivalence regulation.